|
|
|
|
| LEADER |
02874nam a22005055i 4500 |
| 001 |
978-3-319-26206-2 |
| 003 |
DE-He213 |
| 005 |
20160211151041.0 |
| 007 |
cr nn 008mamaa |
| 008 |
160210s2016 gw | s |||| 0|eng d |
| 020 |
|
|
|a 9783319262062
|9 978-3-319-26206-2
|
| 024 |
7 |
|
|a 10.1007/978-3-319-26206-2
|2 doi
|
| 040 |
|
|
|d GrThAP
|
| 050 |
|
4 |
|a RM315-334
|
| 072 |
|
7 |
|a MMGW
|2 bicssc
|
| 072 |
|
7 |
|a MED105020
|2 bisacsh
|
| 082 |
0 |
4 |
|a 615.78
|2 23
|
| 100 |
1 |
|
|a Kudo, Takashi.
|e author.
|
| 245 |
1 |
0 |
|a Practical Pharmacology for Alzheimer’s Disease
|h [electronic resource] /
|c by Takashi Kudo, Kenneth L. Davis, Rafael Blesa Gonzalez, David George Wilkinson.
|
| 250 |
|
|
|a 1st ed. 2016.
|
| 264 |
|
1 |
|a Cham :
|b Springer International Publishing :
|b Imprint: Springer,
|c 2016.
|
| 300 |
|
|
|a VIII, 141 p. 27 illus., 9 illus. in color.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a text file
|b PDF
|2 rda
|
| 505 |
0 |
|
|a Basic theory of pharmacology for Alzheimer’s disease -- Practical Pharmacology of Donepezil -- Practical pharmacology of Galantamine -- Practical pharmacology of Rivastigmine -- Practical Pharmacology of Memantine -- How do we use Symptomatic drugs for Dementia.
|
| 520 |
|
|
|a The wide acceptance of the amyloid cascade hypothesis has led to vigorous development of disease-modifying drugs for Alzheimer’s disease, such as amyloid vaccinations and gamma- or beta-secretase inhibitors. However, the fact that clinical trials of these drugs have not yet yielded satisfactory results has meant that for the time being patients continue to be treated only with symptomatic drugs. Currently, four such drugs are available: donepezil, galantamine, rivastigmine, and memantine. In this book, the four leading experts on each of these drugs explain their practical pharmacology with the aim of providing a sound basis for their use, which to date has been of questionable proficiency. In addition, an introductory chapter considers the basic theory of pharmacology for Alzheimer’s disease and the book closes with an overview of the ways in which symptomatic drugs are used for dementia.
|
| 650 |
|
0 |
|a Medicine.
|
| 650 |
|
0 |
|a Neurology.
|
| 650 |
|
0 |
|a Psychopharmacology.
|
| 650 |
|
0 |
|a Pharmacotherapy.
|
| 650 |
1 |
4 |
|a Medicine & Public Health.
|
| 650 |
2 |
4 |
|a Psychopharmacology.
|
| 650 |
2 |
4 |
|a Neurology.
|
| 650 |
2 |
4 |
|a Pharmacotherapy.
|
| 700 |
1 |
|
|a Davis, Kenneth L.
|e author.
|
| 700 |
1 |
|
|a Blesa Gonzalez, Rafael.
|e author.
|
| 700 |
1 |
|
|a Wilkinson, David George.
|e author.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9783319262048
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1007/978-3-319-26206-2
|z Full Text via HEAL-Link
|
| 912 |
|
|
|a ZDB-2-SME
|
| 950 |
|
|
|a Medicine (Springer-11650)
|
